Immunomodulatory Therapy for Vogt-Koyanagi-Harada Patients as First-Line Therapy

By Paredes I.   Ahmed M.   Foster C.  

Ocular Immunology and Inflammation, Vol. 14, Iss. 2, 2006-03 ,pp. : 87-90

Informa Healthcare

Access to resources Recommend Favorite

Lymphopenia following the completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma

By Aoki Tomohiro   Nishiyama Takahiro   Imahashi Nobuhiko   Kitamura Kunio  

Annals of Hematology, Vol. 91, Iss. 3, 2012-03 ,pp. : 375-382

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab Therapy for Refractory Idiopathic Scleritis

By Bogdanic-Werner Katherine   Fernandez-Sanz Guillermo   Alejandre Alba Nicolás   Ferrer Soldevila Patricia   Romero-Bueno Fredeswinda I.   Sanchez-Pernaute Olga  

Ocular Immunology and Inflammation, Vol. 21, Iss. 4, 2013-08 ,pp. : 329-332

Informa Healthcare

Access to resources Recommend Favorite

Corticosteroid-associated Osteonecrosis: A Rare, but Serious, Complication in Uveitis*

By Smith Wendy M.   Larson Theresa A.   Meleth A. Dhanu   Krishnadev Nupura   Nussenblatt Robert B.   Sen H. Nida  

Ocular Immunology and Inflammation, Vol. 21, Iss. 2, 2013-04 ,pp. : 102-107

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel-based therapy with and without antiangiogenic agents as first-line chemotherapy for castration-resistant prostate cancer: A meta-analysis of nine randomized controlled trials

By              

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1182-1188

Spandidos Publications

Access to resources Recommend Favorite